BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 24720806)

  • 1. Comparison of conjugation strategies of cross-bridged macrocyclic chelators with cetuximab for copper-64 radiolabeling and PET imaging of EGFR in colorectal tumor-bearing mice.
    Zeng D; Guo Y; White AG; Cai Z; Modi J; Ferdani R; Anderson CJ
    Mol Pharm; 2014 Nov; 11(11):3980-7. PubMed ID: 24720806
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Ocak M; Beaino W; White A; Zeng D; Cai Z; Anderson CJ
    Cancer Biother Radiopharm; 2018 Mar; 33(2):74-83. PubMed ID: 29634417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 64Cu-labeled somatostatin analogues conjugated with cross-bridged phosphonate-based chelators via strain-promoted click chemistry for PET imaging: in silico through in vivo studies.
    Cai Z; Ouyang Q; Zeng D; Nguyen KN; Modi J; Wang L; White AG; Rogers BE; Xie XQ; Anderson CJ
    J Med Chem; 2014 Jul; 57(14):6019-29. PubMed ID: 24983404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting cetuximab accumulation in KRAS wild-type and KRAS mutant colorectal cancer using 64Cu-labeled cetuximab positron emission tomography.
    Achmad A; Hanaoka H; Yoshioka H; Yamamoto S; Tominaga H; Araki T; Ohshima Y; Oriuchi N; Endo K
    Cancer Sci; 2012 Mar; 103(3):600-5. PubMed ID: 22126621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor-binding, biodistribution, and metabolism studies of 64Cu-DOTA-cetuximab, a PET-imaging agent for epidermal growth-factor receptor-positive tumors.
    Ping Li W; Meyer LA; Capretto DA; Sherman CD; Anderson CJ
    Cancer Biother Radiopharm; 2008 Apr; 23(2):158-71. PubMed ID: 18454685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PET imaging of very late antigen-4 in melanoma: comparison of 68Ga- and 64Cu-labeled NODAGA and CB-TE1A1P-LLP2A conjugates.
    Beaino W; Anderson CJ
    J Nucl Med; 2014 Nov; 55(11):1856-63. PubMed ID: 25256059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative PET of EGFR expression in xenograft-bearing mice using 64Cu-labeled cetuximab, a chimeric anti-EGFR monoclonal antibody.
    Cai W; Chen K; He L; Cao Q; Koong A; Chen X
    Eur J Nucl Med Mol Imaging; 2007 Jun; 34(6):850-8. PubMed ID: 17262214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved Conjugation, 64-Cu Radiolabeling, in Vivo Stability, and Imaging Using Nonprotected Bifunctional Macrocyclic Ligands: Bis(Phosphinate) Cyclam (BPC) Chelators.
    David T; Hlinová V; Kubíček V; Bergmann R; Striese F; Berndt N; Szöllősi D; Kovács T; Máthé D; Bachmann M; Pietzsch HJ; Hermann P
    J Med Chem; 2018 Oct; 61(19):8774-8796. PubMed ID: 30180567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of two cross-bridged macrocyclic chelators for the evaluation of 64Cu-labeled-LLP2A, a peptidomimetic ligand targeting VLA-4-positive tumors.
    Jiang M; Ferdani R; Shokeen M; Anderson CJ
    Nucl Med Biol; 2013 Feb; 40(2):245-51. PubMed ID: 23265977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and biological evaluation of (64)Cu labeled Tyr(3)-octreotate using a phosphonic acid-based cross-bridged macrocyclic chelator.
    Guo Y; Ferdani R; Anderson CJ
    Bioconjug Chem; 2012 Jul; 23(7):1470-7. PubMed ID: 22663248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of (64)Cu-complexing bifunctional chelators for radioimmunoconjugation: labeling efficiency, specific activity, and in vitro/in vivo stability.
    Cooper MS; Ma MT; Sunassee K; Shaw KP; Williams JD; Paul RL; Donnelly PS; Blower PJ
    Bioconjug Chem; 2012 May; 23(5):1029-39. PubMed ID: 22471317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PET of EGFR antibody distribution in head and neck squamous cell carcinoma models.
    Niu G; Li Z; Xie J; Le QT; Chen X
    J Nucl Med; 2009 Jul; 50(7):1116-23. PubMed ID: 19525473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cetuximab-based immunotherapy and radioimmunotherapy of head and neck squamous cell carcinoma.
    Niu G; Sun X; Cao Q; Courter D; Koong A; Le QT; Gambhir SS; Chen X
    Clin Cancer Res; 2010 Apr; 16(7):2095-105. PubMed ID: 20215534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immuno-PET Imaging and Radioimmunotherapy of 64Cu-/177Lu-Labeled Anti-EGFR Antibody in Esophageal Squamous Cell Carcinoma Model.
    Song IH; Lee TS; Park YS; Lee JS; Lee BC; Moon BS; An GI; Lee HW; Kim KI; Lee YJ; Kang JH; Lim SM
    J Nucl Med; 2016 Jul; 57(7):1105-11. PubMed ID: 26917708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PET Imaging of HER2-Positive Tumors with Cu-64-Labeled Affibody Molecules.
    Qi S; Hoppmann S; Xu Y; Cheng Z
    Mol Imaging Biol; 2019 Oct; 21(5):907-916. PubMed ID: 30617730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immuno-PET imaging for non-invasive assessment of cetuximab accumulation in non-small cell lung cancer.
    Yamaguchi A; Achmad A; Hanaoka H; Heryanto YD; Bhattarai A; Ratianto ; Khongorzul E; Shintawati R; Kartamihardja AAP; Kanai A; Sugo Y; S Ishioka N; Higuchi T; Tsushima Y
    BMC Cancer; 2019 Oct; 19(1):1000. PubMed ID: 31651282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo characterization of 64Cu-labeled Abegrin, a humanized monoclonal antibody against integrin alpha v beta 3.
    Cai W; Wu Y; Chen K; Cao Q; Tice DA; Chen X
    Cancer Res; 2006 Oct; 66(19):9673-81. PubMed ID: 17018625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlating EGFR expression with receptor-binding properties and internalization of 64Cu-DOTA-cetuximab in 5 cervical cancer cell lines.
    Eiblmaier M; Meyer LA; Watson MA; Fracasso PM; Pike LJ; Anderson CJ
    J Nucl Med; 2008 Sep; 49(9):1472-9. PubMed ID: 18703609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo evaluation of pretargeted 64Cu for tumor imaging and therapy.
    Lewis MR; Wang M; Axworthy DB; Theodore LJ; Mallet RW; Fritzberg AR; Welch MJ; Anderson CJ
    J Nucl Med; 2003 Aug; 44(8):1284-92. PubMed ID: 12902420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Click-chemistry strategy for labeling antibodies with copper-64 via a cross-bridged tetraazamacrocyclic chelator scaffold.
    Kumar A; Hao G; Liu L; Ramezani S; Hsieh JT; Öz OK; Sun X
    Bioconjug Chem; 2015 Apr; 26(4):782-9. PubMed ID: 25760776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.